Biotechnology
Cancer
Discovery
Development
Unitedstates
Acquisition
Therapeutics
M&A Advisory
Lazard
Full Credential Description
Kosan Biosciences. United States. Announced Date 29/05/2008. Closed Date 26/06/2008. Deal value: $190m. Bristol-Myers Squibb to acquire Kosan. Industry: Kosan Biosciences is a biotechnology company focused on the discovery and development of cancer therapeutics.